Ipo
U.S. IPO Weekly Recap: CRISPR Biotech Pops 44% As More Names Join The IPO Pipeline
S
Seeking Alpha
Published: Jul 25, 2026, 01:30 PM GMT+9
Sentiment Analysis
Somewhat Bullish0.60
BEARISHNEUTRALBULLISH
One IPO priced this past week, joined by four SPACs. Cardiovascular disease biotech Scribe Therapeutics (SCTX) upsized and priced at the high end to raise $129 million at a $273 million market cap. Scribe is developing in
Sponsored
Source: Seeking Alpha
This content is not intended as investment advice or a recommendation. Any opinions expressed are solely the personal views of each article.